Categories: Market Research

Coronary Artery Bypass Graft Market Size and Forecast 2024-2033|MicroPort Scientific Corporation, CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic PLC

The Coronary Artery Bypass Graft Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Coronary Artery Bypass Graft Market:

https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

According to The Business Research Company’s Coronary Artery Bypass Graft Global Market Report 2024, The coronary artery bypass graft market size has grown strongly in recent years. It will grow from $11.45 billion in 2023 to $12.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to aging population, healthcare infrastructure growth, rising cardiovascular diseases, awareness campaigns, insurance coverage

The coronary artery bypass graft market size is expected to see strong growth in the next few years. It will grow to $17.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to ambulatory surgery centers (ascs) growth, digital health integration, telemedicine growth, remote patient monitoring devices, patient-centric approaches. Major trends in the forecast period include advancements in surgical techniques, collaborative research, robotics in surgery, biodegradable implants, ai for diagnostic purposes, virtual reality training for surgeons.

Increased prevalence of cardiovascular diseases is expected to drive the growth of the coronary artery bypass graft market going forward. Cardiovascular disease (CVD) broadly encompasses various heart and blood vessel ailments. A coronary artery bypass graft (CABG) is recommended to reduce the chances of having a heart attack by creating a new pathway for blood to flow around blocked or partially blocked arteries in the heart. For instance, in March 2023, according to the journal published by Oxford University Press, a UK-based university press of the University of Oxford, by 2045, the percentage of people affected with peripheral artery diseases would increase by 50%. Therefore, the increased prevalence of cardiovascular diseases is driving the growth of the coronary artery bypass graft market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12673&type=smp

The coronary artery bypass graft market covered in this report is segmented –

1) By Procedure: Single Coronary Artery Bypass Graft (CABG) Surgery, Double Coronary Artery Bypass Graft (CABG) Surgery, Triple Coronary Artery Bypass Graft (CABG) Surgery, Quadruple Coronary Artery Bypass Graft (CABG) Surgery, Other Procedures

2) By Method: Off-pump, On-pump

3) By End-Use: Hospitals, Cardiology Clinics, Research Institutes, Other End-Users

Strategic collaboration is a key trend gaining popularity in the coronary artery bypass graft market. Major companies operating in the coronary artery bypass graft market are focused on a strategic collaboration to strengthen their position and gain a competitive advantage. For instance, in July 2022, Medtronic plc, a US-based medical device company, collaborated with CathWorks, an Israel-based medical equipment manufacturer. Under the agreement, Medtronic will invest a maximum of $75 million in the Israel-based company and engage in joint promotion of CathWorks’ FFRangio System in the United States, Japan, and Europe. Furthermore, in September 2021, Etiometry, a US-based clinical decision-support software for critical care, collaborated with Terumo Cardiovascular, a US-based manufacturer of medical devices for cardiac and vascular surgery. Through the partnership, adult cardiac surgery patients will benefit from advanced clinical decision support during and throughout their post-surgical recovery. By combining Etiometry’s platform with Terumo’s cardiac surgical devices, a more comprehensive understanding of a patient’s condition and enhanced perioperative management can be achieved.

The coronary artery bypass graft market report table of contents includes:

1. Executive Summary

2. Coronary Artery Bypass Graft Market Characteristics

3. Coronary Artery Bypass Graft Market Trends And Strategies

4. Coronary Artery Bypass Graft Market – Macro Economic Scenario

5. Global Coronary Artery Bypass Graft Market Size and Growth

26. South America Coronary Artery Bypass Graft Market

27. Brazil Coronary Artery Bypass Graft Market

28. Middle East Coronary Artery Bypass Graft Market

29. Africa Coronary Artery Bypass Graft Market

30. Coronary Artery Bypass Graft Market Competitive Landscape And Company Profiles

Top Major Players: